We’re thrilled to be working with @Novartis to develop oral covalent inhibitors directed at a transcription factor, and historically hard-to-drug protein, linked to a number of inflammatory diseases. bit.ly/40vzkfJ
Matchpoint brings together passionate drug hunters, technical experts, and seasoned company builders - unified by our values and the goal of developing precision covalent medicines that transform the lives of those impacted by serious disease. matchpointtx.com
Edward Chouchani comments on how our ACE platform can overcome the challenges that previously limited the development of precision covalent medicines. bit.ly/3S2nFOf
The resurgence of covalent medicines ~15 years ago led to important medicines. With our Series A, we are building on this legacy by deploying the power of covalency to the field of immunology. Chairman of our BOD, Bruce Booth, comments. bit.ly/3S2nFOf@LifeSciVC
Our Co-founder Nathanael Gray shares his thoughts on where our platform can go, and how it has the potential to screen for highly selective medicines early in the discovery process. bit.ly/3S2nFOf
At Matchpoint we’re exclusively developing covalent medicines and have set our sights on transforming the treatment of serious immune diseases. bit.ly/3S2nFOf
Today we announced the launch of Matchpoint Therapeutics - founded to harness the power of covalency to develop precision small molecule medicines for immune diseases. Check out the press release here. bit.ly/3S2nFOf
694 Followers 1K FollowingI write software for scientists doing drug discovery and cancer research. Interested in: Java, Micronaut, Web Components, REST, Cancer Biology
1.7M Followers 1.7M Following🙏#BeHappy🙏#SoyezHeureux🙏
LA VIE Claire comme de l'eau de roche, Transparente & Pure A Journey of a Thousand Miles Begin With A First Step
83 Followers 1K FollowingBiopharma Bytes stands at the forefront of transforming how professionals digest the latest developments in biopharmaceuticals - one byte at a time.
56K Followers 736 FollowingEarly stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
221 Followers 643 FollowingAssociate Professor & Principal Research Fellow, with research interests in muscle, exercise and hypoxia, IHES, Victoria University, Australia
835 Followers 2K FollowingAgent-ready omics for fast-moving scientists. Proteomics, metabolomics and transcriptomics, connected and reproducible. Your discoveries compound on us.
183 Followers 395 FollowingPostdoc, University of Tennessee, Knoxville, USA.
PhD (Bioconjugation, Antibody Drug Conjugation, Organic Synthesis) @IISERBHOPAL, India.
5 Followers 298 Followinghttps://t.co/FobzrzniuW. Microbiology graduate with four year research experience in infection and structural biology, interested in pursuing a translational Ph.D.
247 Followers 624 FollowingProcure-to-Pay Down to a Science. Founded in 2007, BioProcure offers strategic sourcing & procurement services and admistrative & accounts payable support.
261 Followers 838 FollowingAccelerating R&D while saving you time and money! Check us out to see why Prendio is the premier eprocurement solution for biotech.
680 Followers 5K FollowingPhD candidate at Monash BDI, study in Glucagon signalling in metabolic control (supervised by Dr Adam Rose, the head of Nutrient Metabolism and Signalling lab)
2K Followers 2K FollowingWe are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
156 Followers 1K FollowingA committed grad student by profession working on metabolic diseases @CSIR-IICB!
Honest, humorous lady and an aficionado of books, music and movies!
77 Followers 111 FollowingDeep-rooted fascination for the intricate world of muscle satellite (stem) cells, and the profound influence of biochemistry on our skeletal muscle physiology
56K Followers 736 FollowingEarly stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.